Nippon Kayaku Co (NP7) Stock Price & Analysis
NP7 Stock Chart & Stats
- Day’s Range
- EUR 11.10 - EUR 11.10
- 52-Week Range
- EUR 7.70 - EUR 12.00
- Previous Close
- EUR 11.50
- Volume
- 0
- Average Volume (3M)
- 0
- Market Cap
- EUR 1.66B
- Enterprise Value
- EUR 311.89B
- Total Cash (Recent Filing)
- EUR 52.42B
- Total Debt (Recent Filing)
- EUR 68.18B
- Price to Earnings (P/E)
- 11.4
- Beta
- 0.48
- Next Earnings
- Nov 10, 2026 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 3.41%
Bulls Say, Bears Say
Bulls Say
Revenue And EPS Growth
Re-accelerating revenue and strong EPS growth indicate improving product demand and operating performance across the business. If sustained, this momentum can strengthen earnings capacity and support investment in specialty chemicals, pharmaceuticals, and safety systems.
Profitability Rebound
The sharp margin recovery shows that the company restored profitability after a weak period. A higher earnings base improves resilience and provides greater capacity to fund research, manufacturing needs, dividends, and future growth.
Conservative Balance Sheet
Low leverage and a substantial equity base reduce financial risk and preserve flexibility through business or industry cycles. This supports continued investment in multiple operating segments without relying excessively on external debt.
Bears Say
Weak Free Cash Flow Conversion
Weak and uneven cash conversion raises concerns about earnings quality and the durability of cash returns. Capital spending or working-capital absorption may continue to limit internally generated funds for investment, debt reduction, or dividends.
Gross Margin Pressure
The sustained decline in gross margin suggests pressure from product mix, pricing, or input costs. Unless offset by productivity or pricing actions, lower gross profitability could constrain future operating leverage and make earnings more sensitive to demand changes.
Earnings Volatility
The large swings in profitability and return on equity indicate meaningful sensitivity to operating conditions, costs, or product mix. This volatility makes the earnings base less predictable and complicates long-term planning and capital allocation.
NP7 FAQ
What was Nippon Kayaku Co’s price range in the past 12 months?
What is Nippon Kayaku Co’s market cap?
When is Nippon Kayaku Co’s upcoming earnings report date?
How were Nippon Kayaku Co’s earnings last quarter?
Is Nippon Kayaku Co overvalued?
Does Nippon Kayaku Co pay dividends?
What is Nippon Kayaku Co’s EPS estimate?
How many shares outstanding does Nippon Kayaku Co have?
What happened to Nippon Kayaku Co’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Nippon Kayaku Co?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Nippon Kayaku Co
Nippon Kayaku Co., Ltd., along with its subsidiary companies, is a global enterprise based in Tokyo, Japan. Established in 1916 and originally known as Nihon Kayaku Seizou Co., Ltd. until its rebranding in 1945, the company specializes in the development, manufacturing, and sale of a diverse range of products across several key sectors. Its Functional and Chemical Business segment supplies advanced materials, including epoxy and UV-curable resins, sealants for LCD and LED screens, maleimide resins, photoresists, and insulating materials crucial for micro-electromechanical systems (MEMS), as well as various cleaning agents. This division also produces a variety of colorants, such as inkjet pigments, textile and paper dyes, and materials used in thermal paper. Furthermore, it manufactures catalysts for acrylic and methacrylic acid production, alongside optical and analytical components like polarizing films, inorganic polarizers, parts for liquid crystal displays and projectors, and components for X-ray analysis. The Pharmaceuticals Business segment focuses on healthcare, offering a portfolio that includes anti-cancer and cancer-related medications, biosimilars, generic drugs, interventional radiology products, and cardiovascular treatments. It also provides bulk pharmaceuticals, drug intermediates, and cancer diagnostic agents, notably featuring GlycoMark, a specialized marker for managing blood sugar levels in diabetes. In the Safety Systems Business segment, the company develops and produces critical automotive safety components, such as airbag inflators, micro gas generators for seatbelt pretensioners, and squibs. Finally, the Agrochemicals Business segment provides solutions for agricultural and public health needs, encompassing agricultural insecticides, herbicides, soil fumigants, and products designed for insanitary pest control. Beyond these core industrial activities, Nippon Kayaku Co., Ltd. also manages real estate leasing services.
- Sector
- Basicmaterials
- Industry
- Chemicals
- CEO
- Shigeyuki Kawamura
- Employees
- 5,946
- Website
- www.nipponkayaku.co.jp
- Address
- Meiji Yasuda Seimei Building, Tokyo, TY, 100-0005, JP
Nippon Kayaku Co (NP7) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 8 | 4 | 10 |
| Technical Analysis | 4 | 4 | 2 |
| Moving Averages | 4 | 0 | 8 |









